A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ

Clinical trial NCT03057912 · UNKNOWN

Trial details

NCT number

NCT03057912

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Status

UNKNOWN

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2018-01-15

Primary completion

2018-11-15

Enrollment

60

View on ClinicalTrials.gov